VMP 42037411000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Memantine 10mg tablets
BNF code 0411000G0AAAAAA
Virtual Therapeutic Moiety Memantine
Date identifier became valid 7 Jul 2023
Previous product identifier 407837006
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Memantine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Ebixa 10mg tablets (Lundbeck Ltd)
Memantine 10mg tablets (A A H Pharmaceuticals Ltd)
Memantine 10mg tablets (Accord-UK Ltd)
Memantine 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Memantine 10mg tablets (Bristol Laboratories Ltd)
Memantine 10mg tablets (Crescent Pharma Ltd)
Memantine 10mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Memantine 10mg tablets (Drugsrus Ltd)
Memantine 10mg tablets (Macleods Pharma UK Ltd)
Memantine 10mg tablets (Medihealth (Northern) Ltd)
Memantine 10mg tablets (Niche Generics Ltd)
Memantine 10mg tablets (Sigma Pharmaceuticals Plc)
Memantine 10mg tablets (Torrent Pharma (UK) Ltd)
Memantine 10mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Memantine 10mg tablets 112 tablet
Memantine 10mg tablets 28 tablet
Memantine 10mg tablets 56 tablet
Memantine 10mg tablets 7 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback